These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 17886172)
21. Malawi's contribution to "3 by 5": achievements and challenges. Libamba E; Makombe SD; Harries AD; Schouten EJ; Yu JK; Pasulani O; Mhango E; Aberle-Grasse J; Hochgesang M; Limbambala E; Lungu D Bull World Health Organ; 2007 Feb; 85(2):156-60. PubMed ID: 17308738 [TBL] [Abstract][Full Text] [Related]
22. Public-sector ART in the Free State Province, South Africa: community support as an important determinant of outcome. Wouters E; Van Damme W; Van Loon F; van Rensburg D; Meulemans H Soc Sci Med; 2009 Oct; 69(8):1177-85. PubMed ID: 19692165 [TBL] [Abstract][Full Text] [Related]
23. Preferences for characteristics of antiretroviral therapy provision in Johannesburg, South Africa: results of a conjoint analysis. Opuni M; Bishai D; Gray GE; McIntyre JA; Martinson NA AIDS Behav; 2010 Aug; 14(4):807-15. PubMed ID: 19533322 [TBL] [Abstract][Full Text] [Related]
24. Who is accessing antiretroviral therapy during national scale-up in Malawi? Makombe S; Libamba E; Mhango E; de Ascurra Teck O; Aberle-Grasse J; Hochgesang M; Schouten EJ; Harries AD Trans R Soc Trop Med Hyg; 2006 Oct; 100(10):975-9. PubMed ID: 16443244 [TBL] [Abstract][Full Text] [Related]
25. User fees and access to ARV treatment for persons living with HIV/AIDS: implementation and challenges in Burkina Faso, a limited-resource country. Kouanda S; Bocoum FY; Doulougou B; Bila B; Yameogo M; Sanou MJ; Sawadogo M; Sondo B; Msellati P; Desclaux A AIDS Care; 2010 Sep; 22(9):1146-52. PubMed ID: 20824567 [TBL] [Abstract][Full Text] [Related]
26. [Impact of access to antiretroviral therapy in Côte d'Ivoire]. Eholié SP; Tanon KA; Folquet-Amorissani M; Ouattara I; Aba YT; Traoré-Ettiegne V; Kakou AR; Aoussi E; Anglaret X; Bissagnéné E Med Trop (Mars); 2009 Oct; 69(5):520-4. PubMed ID: 20025190 [TBL] [Abstract][Full Text] [Related]
27. A report on the Zimbabwe Antiretroviral Therapy (ART) programme progress towards achieving MGD6 target 6B: achievement and challenges. Apollo T; Takarinda K; Mugurungi O; Chakanyuka C; Simbini T; Harries AD Cent Afr J Med; 2010; 56(1-4):12-4. PubMed ID: 23457867 [TBL] [Abstract][Full Text] [Related]
28. A case study of the provision of antiretroviral therapy for refugees in Tanzania. Stephen H; Roberts B Med Confl Surviv; 2009; 25(2):134-47. PubMed ID: 19655639 [TBL] [Abstract][Full Text] [Related]
29. Surveillance of transmitted HIV drug resistance with the World Health Organization threshold survey method in Lilongwe, Malawi. Kamoto K; Aberle-Grasse J; Antivir Ther; 2008; 13 Suppl 2():83-7. PubMed ID: 18575195 [TBL] [Abstract][Full Text] [Related]
30. The public health approach to antiretroviral treatment (ART) service scale-up in Ethiopia: the first two years of free ART, 2005-2007. Assefa Y; Kloos H Ethiop Med J; 2008 Oct; 46(4):401-6. PubMed ID: 19271406 [TBL] [Abstract][Full Text] [Related]
31. The impact of Global Health Initiatives at national and sub-national level - a policy analysis of their role in implementation processes of antiretroviral treatment (ART) roll-out in Zambia and South Africa. Hanefeld J AIDS Care; 2010; 22 Suppl 1():93-102. PubMed ID: 20680864 [TBL] [Abstract][Full Text] [Related]
32. Outcomes of patients with Kaposi's sarcoma who start antiretroviral therapy under routine programme conditions in Malawi. Makombe SD; Harries AD; Yu JK; Hochgesang M; Mhango E; Weigel R; Pasulani O; Fitzgerald M; Schouten EJ; Libamba E Trop Doct; 2008 Jan; 38(1):5-7. PubMed ID: 18302849 [TBL] [Abstract][Full Text] [Related]
33. Obstacles and proposed solutions to effective antiretroviral therapy in resource-limited settings. Bartlett JA; Hornberger J; Shewade A; Bhor M; Rajagopalan R J Int Assoc Physicians AIDS Care (Chic); 2009; 8(4):253-68. PubMed ID: 19721103 [TBL] [Abstract][Full Text] [Related]
34. Introduction: the realities of antiretroviral therapy rollout: overcoming challenges to successful programmatic implementation. Ojikutu B J Infect Dis; 2007 Dec; 196 Suppl 3():S445-8. PubMed ID: 18181692 [TBL] [Abstract][Full Text] [Related]
35. Recurrent costs of HIV/AIDS-related health services in Rwanda: implications for financing. Quentin W; König HH; Schmidt JO; Kalk A Trop Med Int Health; 2008 Oct; 13(10):1245-56. PubMed ID: 18721185 [TBL] [Abstract][Full Text] [Related]
36. Early warning indicators for HIV drug resistance in Malawi. Hedt BL; Wadonda-Kabondo N; Makombe S; Harries AD; Schouten EJ; Limbambala E; Hochgesang M; Aberle-Grosse J; Kamoto K Antivir Ther; 2008; 13 Suppl 2():69-75. PubMed ID: 18575193 [TBL] [Abstract][Full Text] [Related]
37. Evidence for Action on HIV Treatment and Care Systems in low and middle-income countries: background and introduction. Ross DA; South A; Weller I; Hakim J AIDS; 2012 Dec; 26 Suppl 2():S93-5. PubMed ID: 23303437 [TBL] [Abstract][Full Text] [Related]
38. Developing a palliative care service for children in the Queen Elizabeth Central Hospital, Blantyre, Malawi. Molyneux EM; Lavy V; Bunn M; Palmer Z; Chiputula F Arch Dis Child; 2013 Sep; 98(9):698-701. PubMed ID: 23898158 [TBL] [Abstract][Full Text] [Related]
39. Outcomes in HIV-infected patients who develop tuberculosis after starting antiretroviral treatment in Malawi. Yu JK; Bong CN; Chen SC; Dzimadzi R; Lu DY; Makombe SD; Schouten EJ; Kamoto K; Harries AD Int J Tuberc Lung Dis; 2008 Jun; 12(6):692-4. PubMed ID: 18492340 [TBL] [Abstract][Full Text] [Related]
40. Epidemiology and mortality of burns at the Queen Elizabeth Central Hospital Blantyre, Malawi. Komolafe OO; James J; Makoka M; Kalongeolera L Cent Afr J Med; 2003; 49(11-12):130-4. PubMed ID: 15301466 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]